The impact of lipoprotein(a) level on cardiac pathologies in diabetes: a cardiac CT study
European Radiology · 2024
DOI: 10.1007/s00330-024-10903-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Radiology, 2024. Verfasst von Jiajun Yuan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, #85 Wujin Rd, Shanghai, China. Hauptthemen laut MEDLINE: Lipoprotein(a), Coronary Artery Disease, Computed Tomography Angiography. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.
Themen: Diabetes mellitus
Abstract (Originalsprache)
OBJECTIVES: We aimed to explore the imaging profile of coronary atherosclerosis, perivascular inflammation, myocardial perfusion, and interstitial fibrosis in diabetes stratified by lipoprotein(a) [Lp(a)] levels. METHODS: In this prospective study, we enrolled diabetic patients who had undergone computed tomography (CT) angiography, stress CT-myocardial perfusion imaging, and late iodine enhancement in 20 months. Then, we categorized them into elevated and normal groups based on an Lp(a) cutoff level of 30 mg/dL. All imaging data, including coronary atherosclerosis parameters, pericoronary adipose tissue (PCAT) density, stress myocardial blood flow (MBF), and extracellular volume (ECV), were collected for further analysis. RESULTS: In total, 207 participants (mean age: 59.1 ± 12.0 years, 111 males) were included in this study. Patients with elevated Lp(a) level had more pronounced percent atheroma volume (2.55% (1.01-9.01%) versus 1.30% (0-4.95%), p = 0.010), and demonstrated a higher incidence of positive remodeling, spotty calcification, and high-risk plaque (HRP) than those with normal Lp(a) levels (75.6% versus 54.8%, p = 0.015; 26.8% versus 9.6%, p = 0.003; 51.2% versus 30.1%, p = 0.011, respectively). Results of the multivariate analysis revealed that after adjusting for all clinical characteristics, elevated Lp(a) levels were an independent parameter associated with HRP (odds ratio = 2.608; 95% confidence interval: 1.254-5.423, p = 0.010). However, no significant difference was found between the two groups in terms of PCAT density, stress MBF, and ECV. CONCLUSIONS: Elevated Lp(a) levels are associated with extensive coronary atherosclerosis and HRP development. However, they are not related to perivascular inflammation, decreased myocardial perfusion, and interstitial fibrosis in diabetes. CLINICAL RELEVANCE STATEMENT: Elevated lipoprotein(a) levels are associated with extensive coronary atherosclerosis and a high incidence of HRPs. However, they are not related to perivascular inflammation, decreased myocardial perfusion, and interstitial fibrosis in diabetes. KEY POINTS: Diabetes is a known risk factor that accelerates cardiovascular disease progression. Diabetics with elevated lipoprotein(a) (Lp(a)) levels had a higher percent atheroma volume and positive remodeling, spotty calcification, and HRPs. Patients with diabetes should be screened for elevated Lp(a) using CCTA for comprehensive evaluation of atherosclerotic characteristics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, #85 Wujin Rd, Shanghai, China.
- Department of Endocrinology and Metabolism, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, #85 Wujin Rd, Shanghai, China.
- Department of Endocrinology and Metabolism, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, #85 Wujin Rd, Shanghai, China. yyffwang@sina.com.
- Department of Radiology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, #85 Wujin Rd, Shanghai, China. andrewssmu@msn.com.
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Yuan, J., Ding, X., Yang, W., Lan, Z., Yu, Y., Yu, L., Dai, X., Wang, Y., & Zhang, J. (2024). The impact of lipoprotein(a) level on cardiac pathologies in diabetes: a cardiac CT study. European Radiology. https://doi.org/10.1007/s00330-024-10903-4
Vancouver
Yuan J, Ding X, Yang W, Lan Z, Yu Y, Yu L, et al. The impact of lipoprotein(a) level on cardiac pathologies in diabetes: a cardiac CT study. European Radiology. 2024. doi:10.1007/s00330-024-10903-4
BibTeX
@article{Yuan2024,
author = {Yuan, Jiajun and Ding, Xiaoying and Yang, Wenli and Lan, Ziting and Yu, Yarong and Yu, Lihua and Dai, Xu and Wang, Yufan and Zhang, Jiayin},
title = {The impact of lipoprotein(a) level on cardiac pathologies in diabetes: a cardiac CT study},
journal = {European Radiology},
year = {2024},
doi = {10.1007/s00330-024-10903-4}
}
EUVIMED